Key points

HIV/AIDS

• Following the 2020 pandemic, reporting levels in Normandy are lower than those observed before the health crisis.

• Testing activity has picked up again, and the rate of positive serology results is decreasing (LaboVIH).

• The adjusted rate of new HIV-positive diagnoses is 37 per million inhabitants in Normandy in 2021, down since 2018 (DO HIV).

• The adjusted rate of AIDS diagnoses in Normandy was estimated at 7 per million inhabitants in 2021 (DO AIDS).

Chlamydia trachomatis (Ct) infection

• The regional screening rate for Ct infections is 31.6 per 1,000 inhabitants of all ages and genders (SNDS).

• The number of Ct infection diagnoses has been steadily increasing in Normandy since 2014 (+29% between 2020 and 2021) (SNDS).

• The positivity rate in CeGIDD was 8.5% in 2021, the highest since 2016 (RAP data).

Gonococcal infection

• In 2021, the screening rate in Normandy reached 38.4 people screened per 1,000 residents aged 15 and older (SNDS).

• The positivity rate at CeGIDD was 2.9% in 2021, the highest since 2016 (RAP data).

Syphilis

• In 2021, the screening rate in Normandy was 41.4 people screened per 1,000 residents aged 15 and older (SNDS).

• The positivity rate in CeGIDD is 0.9% in 2021, the highest since 2017 (RAP data).